Literature DB >> 12074922

Proton MR spectroscopy in Rett syndrome.

A Gökcay1, O Kitis, O Ekmekci, H Karasoy, R N Sener.   

Abstract

Seven patients (mean age 7.7yr) with Rett syndrome, a condition with progressive regression of psychomotor development are included in this study. Proton MR spectroscopy images were obtained with the multivoxel chemical-shift imaging mode (TR=1500ms, TE=40ms). Spectra from 224 voxels in the brain parenchyma were studied. N-acetyl aspartate (NAA), creatine (Cr), choline (Cho), and myoinositol (mI) peaks were quantitatively evaluated, and NAA/Cr, NAA/Cho, and Cho/Cr, mI/Cr ratios were calculated. Five age-matched normal cases were available as controls. In three patients with Rett syndrome spectroscopy findings were normal, and the metabolite ratios were similar to control cases. In the remaining four patients with the syndrome prominent decrease of the NAA peak was the main finding resulting in decreases in NAA/Cr (1.14+/-17), and NAA/Cho (1.08+/-27) ratios (p<0.0001). Cho/Cr ratios (0.93+/-26), and mI/Cr ratios (0.88+/-36) were normal compared to controls. There was no correlation between spectroscopic changes and clinical status of the patients. The findings suggested that not only reduced neuronal-dendritic arborizations but also decreased neuronal function could contribute to spectroscopy changes in Rett syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12074922     DOI: 10.1016/s0895-6111(02)00016-2

Source DB:  PubMed          Journal:  Comput Med Imaging Graph        ISSN: 0895-6111            Impact factor:   4.790


  7 in total

1.  Altered carbon dioxide metabolism and creatine abnormalities in rett syndrome.

Authors:  Nicky S J Halbach; Eric E J Smeets; Jörgen Bierau; Irene M L W Keularts; Guy Plasqui; Peter O O Julu; Ingegerd Witt Engerström; Jaap A Bakker; Leopold M G Curfs
Journal:  JIMD Rep       Date:  2011-09-28

Review 2.  Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease.

Authors:  Natalia A Stefanova; Oyuna S Kozhevnikova; Anton O Vitovtov; Kseniya Yi Maksimova; Sergey V Logvinov; Ekaterina A Rudnitskaya; Elena E Korbolina; Natalia A Muraleva; Nataliya G Kolosova
Journal:  Cell Cycle       Date:  2014-02-17       Impact factor: 4.534

3.  Selective cerebral volume reduction in Rett syndrome: a multiple-approach MR imaging study.

Authors:  J C Carter; D C Lanham; D Pham; G Bibat; S Naidu; W E Kaufmann
Journal:  AJNR Am J Neuroradiol       Date:  2007-12-07       Impact factor: 3.825

4.  Brain metabolism in Rett syndrome: age, clinical, and genotype correlations.

Authors:  Alena Horská; Luciano Farage; Genila Bibat; Lídia M Nagae; Walter E Kaufmann; Peter B Barker; SakkuBai Naidu
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

5.  Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model.

Authors:  Angèle Viola; Véronique Saywell; Laurent Villard; Patrick J Cozzone; Norbert W Lutz
Journal:  PLoS One       Date:  2007-01-17       Impact factor: 3.240

Review 6.  Multimodal Neuroimaging in Rett Syndrome With MECP2 Mutation.

Authors:  Yu Kong; Qiu-Bo Li; Zhao-Hong Yuan; Xiu-Fang Jiang; Gu-Qing Zhang; Nan Cheng; Na Dang
Journal:  Front Neurol       Date:  2022-02-23       Impact factor: 4.003

7.  Choline Rescues Behavioural Deficits in a Mouse Model of Rett Syndrome by Modulating Neuronal Plasticity.

Authors:  Eunice W M Chin; Wee Meng Lim; Dongliang Ma; Francisco J Rosales; Eyleen L K Goh
Journal:  Mol Neurobiol       Date:  2018-09-15       Impact factor: 5.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.